HPUS Timeline and Statistics

From its earliest roots in 19th century pharmacopeias to its modern digital format, the Homoeopathic Pharmacopeia of the United States (HPUS) has evolved alongside the regulatory landscape. This newly added…

Read More

The FDA Adverse Event Reporting System (FAERS)

By Kristina Skowronek, Dir. of Quality and Regulatory Compliance, Boiron, Inc. The FDA Adverse Event Reporting System (FAERS) has a public dashboard online where healthcare practitioners, retailers, consumers, and industry…

Read More

AAHP Reader Favorites for 2024

As we wrap up 2024, we’d like to take a moment to look back at our top articles from this year. These top five reads captured the attention of our…

Read More

New Rand Research Report: The State of Homeopathic Research

The Federal Trade Commission recently published rules regarding consumer endorsements and testimonials which take effect in less than two months. The rules are wide ranging and cover: relationships , compensation, prohibitions, misrepresentation or far more. Violators will be fined under the new rules. The AAHP has prepared a brief overview of …

Read More

2024 Year in Review

By Mark Land, MS, RAC-US, AAHP President As 2024 comes to a close, let’s reflect on some of the news related to homeopathy and AAHP’s achievements. General News Affecting Homeopathy…

Read More

Lawsuit Challenges FDA’s Homeopathic Regulatory Policy

The Federal Trade Commission recently published rules regarding consumer endorsements and testimonials which take effect in less than two months. The rules are wide ranging and cover: relationships , compensation, prohibitions, misrepresentation or far more. Violators will be fined under the new rules. The AAHP has prepared a brief overview of …

Read More